Back to search

Article

Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation

2022-02-23

Abstract excerpt

<h4>Objective: </h4> This study was to explore the most appropriate radiomics modeling method to predict the progression-free survival of EGFR-TKI treatment in advanced non-small cell lung cancer with EGFR mutations. Different machine learning methods may vary considerably and the selection of a proper model is essential for accurate treatment outcome prediction. Our study were established 176 discrimination model...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
85d2d637-8f3c-56ff-b42a-447b0c5f591b
DOI
10.21203/rs.3.rs-1100268/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutationDOI 10.21203/rs.3.rs-1100268/v1
Select a neighboring publication to make it the new centre.